Based on closing prices on 16 October 2026, NANO Holdings, Kojin Bio and Stella Pharma rose, while Veritas in Silico, Delta-Fly Pharm and Oncolys BioPharma fell sharply.
According to Nikkei Biotechnology ONLINE's weekly report on biotech venture stock prices, 12 stocks rose from the previous weekend, while 45 fell. NANO Holdings posted the largest gain at +12.7%, followed by Kojin Bio at +4.0% and Stella Pharma at +2.8%.
Among the stocks with the steepest declines, Veritas in Silico fell 20.9%, Delta-Fly Pharm fell 15.2% and Oncolys BioPharma fell 13.2%. The table compares closing prices and shows changes from 9 October to 16 October.
Among the top 3 stocks, NANO Holdings' closing price rose from 79 to 89, Kojin Bio's from 815 to 848 and Stella Pharma's from 394 to 405. Among the bottom 3 stocks, Oncolys BioPharma fell from 5970 to 5180, Delta-Fly Pharm from 99 to 84 and Veritas in Silico from 426 to 337.